| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metabolic Syndrome | 40 | 2024 | 345 | 8.540 |
Why?
|
| C-Reactive Protein | 67 | 2023 | 442 | 8.050 |
Why?
|
| Monocytes | 38 | 2021 | 330 | 5.380 |
Why?
|
| Inflammation | 48 | 2024 | 1433 | 4.110 |
Why?
|
| Diabetes Mellitus, Type 1 | 24 | 2026 | 824 | 3.480 |
Why?
|
| Blood Chemical Analysis | 9 | 2021 | 84 | 2.590 |
Why?
|
| Antioxidants | 23 | 2017 | 322 | 2.530 |
Why?
|
| Diabetes Mellitus | 10 | 2024 | 873 | 2.520 |
Why?
|
| Cholesterol, LDL | 16 | 2021 | 604 | 2.520 |
Why?
|
| Biomarkers | 55 | 2024 | 3235 | 2.510 |
Why?
|
| Plant Extracts | 12 | 2024 | 133 | 2.430 |
Why?
|
| Lipids | 17 | 2021 | 550 | 2.420 |
Why?
|
| Cholesterol | 14 | 2019 | 536 | 2.380 |
Why?
|
| Hemoglobins, Abnormal | 3 | 2024 | 12 | 2.250 |
Why?
|
| Cytokines | 25 | 2022 | 1325 | 2.210 |
Why?
|
| Endothelium, Vascular | 20 | 2018 | 460 | 2.200 |
Why?
|
| Humans | 279 | 2026 | 127335 | 2.170 |
Why?
|
| Hemoglobinopathies | 3 | 2023 | 17 | 2.140 |
Why?
|
| Immunoassay | 8 | 2023 | 130 | 2.090 |
Why?
|
| Endothelial Cells | 17 | 2018 | 504 | 2.040 |
Why?
|
| Cystatin C | 3 | 2024 | 69 | 1.990 |
Why?
|
| Hypertriglyceridemia | 4 | 2022 | 114 | 1.930 |
Why?
|
| Toll-Like Receptor 4 | 12 | 2015 | 137 | 1.930 |
Why?
|
| Glucose Tolerance Test | 5 | 2025 | 199 | 1.910 |
Why?
|
| Blood Glucose | 14 | 2025 | 1082 | 1.860 |
Why?
|
| Diabetes Mellitus, Experimental | 7 | 2018 | 140 | 1.830 |
Why?
|
| Chemistry, Clinical | 3 | 2023 | 11 | 1.790 |
Why?
|
| alpha-Tocopherol | 14 | 2010 | 36 | 1.780 |
Why?
|
| Dietary Supplements | 17 | 2017 | 440 | 1.750 |
Why?
|
| Oxidative Stress | 24 | 2020 | 756 | 1.710 |
Why?
|
| Atherosclerosis | 19 | 2021 | 929 | 1.700 |
Why?
|
| Betacoronavirus | 4 | 2020 | 285 | 1.680 |
Why?
|
| Macrophages | 15 | 2024 | 644 | 1.650 |
Why?
|
| Toll-Like Receptor 2 | 11 | 2015 | 55 | 1.630 |
Why?
|
| Cardiovascular Diseases | 21 | 2024 | 2036 | 1.620 |
Why?
|
| Clinical Laboratory Techniques | 3 | 2025 | 146 | 1.610 |
Why?
|
| Diabetes, Gestational | 2 | 2025 | 107 | 1.570 |
Why?
|
| Postpartum Period | 2 | 2025 | 227 | 1.570 |
Why?
|
| Glomerular Filtration Rate | 5 | 2024 | 539 | 1.510 |
Why?
|
| Male | 144 | 2026 | 62795 | 1.490 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 16 | 2020 | 787 | 1.460 |
Why?
|
| Female | 130 | 2026 | 68638 | 1.440 |
Why?
|
| Diabetic Angiopathies | 7 | 2013 | 66 | 1.440 |
Why?
|
| Insulin Resistance | 12 | 2024 | 665 | 1.420 |
Why?
|
| Clinical Laboratory Services | 3 | 2020 | 15 | 1.420 |
Why?
|
| Bilirubin | 4 | 2023 | 124 | 1.380 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 363 | 1.380 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 376 | 1.370 |
Why?
|
| Blood Specimen Collection | 3 | 2021 | 45 | 1.360 |
Why?
|
| Arteriosclerosis | 13 | 2008 | 113 | 1.350 |
Why?
|
| Triglycerides | 16 | 2024 | 596 | 1.350 |
Why?
|
| Child | 55 | 2026 | 25299 | 1.330 |
Why?
|
| Creatinine | 7 | 2024 | 384 | 1.290 |
Why?
|
| NF-kappa B | 23 | 2019 | 438 | 1.290 |
Why?
|
| Gastrointestinal Microbiome | 8 | 2022 | 796 | 1.270 |
Why?
|
| Cardiology | 3 | 2019 | 488 | 1.240 |
Why?
|
| Biological Assay | 3 | 2015 | 106 | 1.230 |
Why?
|
| Receptors, IgG | 9 | 2013 | 56 | 1.210 |
Why?
|
| Adult | 76 | 2026 | 30544 | 1.190 |
Why?
|
| Obesity | 14 | 2022 | 2337 | 1.180 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 11 | 2021 | 734 | 1.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 16 | 2025 | 1357 | 1.160 |
Why?
|
| Tandem Mass Spectrometry | 5 | 2024 | 276 | 1.140 |
Why?
|
| Adolescent | 45 | 2026 | 20151 | 1.100 |
Why?
|
| Subcutaneous Fat | 6 | 2020 | 34 | 1.100 |
Why?
|
| Glucose | 9 | 2020 | 839 | 1.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 16 | 2015 | 638 | 1.070 |
Why?
|
| Estradiol | 3 | 2019 | 477 | 1.070 |
Why?
|
| Antibodies, Viral | 4 | 2023 | 1133 | 1.060 |
Why?
|
| Cystic Fibrosis | 2 | 2024 | 263 | 1.060 |
Why?
|
| Phytosterols | 4 | 2011 | 28 | 1.050 |
Why?
|
| Fertilization in Vitro | 2 | 2019 | 155 | 1.040 |
Why?
|
| Anti-Inflammatory Agents | 7 | 2015 | 296 | 1.030 |
Why?
|
| Dyslipidemias | 4 | 2021 | 235 | 1.030 |
Why?
|
| Practice Guidelines as Topic | 5 | 2025 | 1273 | 1.000 |
Why?
|
| Interleukin-6 | 15 | 2019 | 406 | 0.980 |
Why?
|
| Fatty Liver | 3 | 2026 | 204 | 0.980 |
Why?
|
| Young Adult | 30 | 2026 | 9698 | 0.970 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2025 | 9 | 0.950 |
Why?
|
| Fasting | 5 | 2020 | 300 | 0.930 |
Why?
|
| Liver Cirrhosis | 7 | 2026 | 874 | 0.920 |
Why?
|
| Toll-Like Receptors | 4 | 2013 | 82 | 0.920 |
Why?
|
| Middle Aged | 60 | 2025 | 27818 | 0.910 |
Why?
|
| Lipoproteins | 5 | 2021 | 183 | 0.900 |
Why?
|
| Anticholesteremic Agents | 6 | 2019 | 239 | 0.880 |
Why?
|
| Inflammation Mediators | 8 | 2018 | 223 | 0.880 |
Why?
|
| Aorta | 14 | 2013 | 518 | 0.880 |
Why?
|
| Cholesterol, HDL | 5 | 2021 | 379 | 0.870 |
Why?
|
| Immunoglobulin M | 3 | 2023 | 210 | 0.850 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 5 | 2011 | 50 | 0.840 |
Why?
|
| Simvastatin | 4 | 2008 | 76 | 0.830 |
Why?
|
| Laboratories, Hospital | 2 | 2021 | 24 | 0.830 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2024 | 34 | 0.830 |
Why?
|
| Beverages | 4 | 2011 | 100 | 0.820 |
Why?
|
| Proanthocyanidins | 3 | 2009 | 8 | 0.820 |
Why?
|
| Adiponectin | 4 | 2011 | 124 | 0.820 |
Why?
|
| Pyrazoles | 3 | 2023 | 330 | 0.820 |
Why?
|
| Vitamin D | 2 | 2023 | 180 | 0.810 |
Why?
|
| Celiac Disease | 2 | 2024 | 75 | 0.790 |
Why?
|
| Reference Values | 10 | 2025 | 684 | 0.790 |
Why?
|
| Superoxides | 11 | 2012 | 129 | 0.790 |
Why?
|
| Artificial Intelligence | 2 | 2025 | 301 | 0.790 |
Why?
|
| Inflammasomes | 3 | 2020 | 149 | 0.780 |
Why?
|
| Reproducibility of Results | 11 | 2025 | 2891 | 0.780 |
Why?
|
| Animals | 68 | 2024 | 33197 | 0.760 |
Why?
|
| Interleukin-1beta | 10 | 2019 | 150 | 0.760 |
Why?
|
| Immunoglobulin G | 4 | 2023 | 773 | 0.750 |
Why?
|
| Adipose Tissue | 7 | 2019 | 476 | 0.750 |
Why?
|
| Hypolipidemic Agents | 5 | 2011 | 183 | 0.740 |
Why?
|
| Acanthosis Nigricans | 1 | 2022 | 8 | 0.740 |
Why?
|
| Lipoproteins, HDL | 2 | 2021 | 96 | 0.730 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 2 | 2025 | 43 | 0.730 |
Why?
|
| Vitamins | 6 | 2023 | 110 | 0.720 |
Why?
|
| Aloe | 2 | 2012 | 4 | 0.720 |
Why?
|
| Diabetic Nephropathies | 2 | 2014 | 113 | 0.720 |
Why?
|
| gamma-Tocopherol | 3 | 2007 | 3 | 0.720 |
Why?
|
| Pediatrics | 3 | 2025 | 1205 | 0.710 |
Why?
|
| NADPH Oxidases | 9 | 2013 | 108 | 0.710 |
Why?
|
| Benzoates | 1 | 2021 | 26 | 0.700 |
Why?
|
| Hydrazines | 1 | 2021 | 28 | 0.700 |
Why?
|
| Dried Blood Spot Testing | 1 | 2021 | 26 | 0.700 |
Why?
|
| Coinfection | 1 | 2023 | 185 | 0.690 |
Why?
|
| Acute Kidney Injury | 4 | 2021 | 664 | 0.690 |
Why?
|
| Hyponatremia | 1 | 2022 | 73 | 0.690 |
Why?
|
| Lipoproteins, LDL | 11 | 2012 | 119 | 0.690 |
Why?
|
| Lipid Metabolism | 6 | 2020 | 355 | 0.680 |
Why?
|
| Ovulation Induction | 1 | 2021 | 39 | 0.680 |
Why?
|
| Retrospective Studies | 19 | 2026 | 17068 | 0.680 |
Why?
|
| Double-Blind Method | 16 | 2016 | 1596 | 0.680 |
Why?
|
| Spike Glycoprotein, Coronavirus | 2 | 2025 | 204 | 0.680 |
Why?
|
| Dysbiosis | 2 | 2022 | 138 | 0.670 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2021 | 43 | 0.670 |
Why?
|
| Myocardial Ischemia | 3 | 2009 | 299 | 0.670 |
Why?
|
| Adiposity | 7 | 2020 | 205 | 0.670 |
Why?
|
| Liver | 15 | 2025 | 1765 | 0.660 |
Why?
|
| Child, Preschool | 22 | 2026 | 14463 | 0.660 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2020 | 125 | 0.660 |
Why?
|
| Virus Diseases | 1 | 2023 | 271 | 0.660 |
Why?
|
| Triiodothyronine, Reverse | 1 | 2020 | 2 | 0.660 |
Why?
|
| Thyroid Function Tests | 1 | 2020 | 17 | 0.650 |
Why?
|
| American Heart Association | 2 | 2019 | 307 | 0.650 |
Why?
|
| Nitric Oxide Synthase Type III | 9 | 2010 | 188 | 0.650 |
Why?
|
| Hyperlipidemias | 7 | 2015 | 181 | 0.650 |
Why?
|
| Chromatography, Liquid | 4 | 2024 | 231 | 0.640 |
Why?
|
| Mass Screening | 2 | 2024 | 803 | 0.640 |
Why?
|
| Cell Adhesion | 9 | 2013 | 299 | 0.640 |
Why?
|
| Bacterial Infections | 1 | 2023 | 321 | 0.640 |
Why?
|
| Rats | 20 | 2022 | 3395 | 0.630 |
Why?
|
| Hemoglobins | 5 | 2023 | 312 | 0.620 |
Why?
|
| Autoimmune Diseases | 1 | 2022 | 270 | 0.620 |
Why?
|
| Case-Control Studies | 19 | 2025 | 3325 | 0.610 |
Why?
|
| Anemia, Sickle Cell | 1 | 2023 | 325 | 0.610 |
Why?
|
| Citrus sinensis | 2 | 2011 | 6 | 0.600 |
Why?
|
| Cells, Cultured | 22 | 2018 | 2898 | 0.590 |
Why?
|
| Pandemics | 3 | 2020 | 1140 | 0.580 |
Why?
|
| Hypercholesterolemia | 5 | 2010 | 230 | 0.580 |
Why?
|
| Ovary | 1 | 2021 | 358 | 0.580 |
Why?
|
| Biliary Atresia | 4 | 2025 | 217 | 0.570 |
Why?
|
| Artifacts | 2 | 2021 | 103 | 0.570 |
Why?
|
| Cell Adhesion Molecules | 3 | 2015 | 216 | 0.570 |
Why?
|
| Infant | 20 | 2026 | 12808 | 0.560 |
Why?
|
| E-Selectin | 3 | 2014 | 38 | 0.560 |
Why?
|
| Interleukin-8 | 9 | 2022 | 204 | 0.560 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2024 | 549 | 0.550 |
Why?
|
| Sensitivity and Specificity | 12 | 2020 | 2075 | 0.550 |
Why?
|
| Leptin | 5 | 2020 | 218 | 0.550 |
Why?
|
| Risk Reduction Behavior | 1 | 2019 | 146 | 0.550 |
Why?
|
| Hypoglycemic Agents | 3 | 2018 | 456 | 0.550 |
Why?
|
| Streptavidin | 1 | 2017 | 4 | 0.550 |
Why?
|
| Indicators and Reagents | 1 | 2017 | 46 | 0.540 |
Why?
|
| Biotin | 1 | 2017 | 39 | 0.540 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2024 | 799 | 0.530 |
Why?
|
| Clinical Chemistry Tests | 2 | 2015 | 5 | 0.530 |
Why?
|
| Child Nutritional Physiological Phenomena | 2 | 2017 | 157 | 0.530 |
Why?
|
| Immunity, Innate | 2 | 2017 | 395 | 0.520 |
Why?
|
| Aged | 28 | 2025 | 20433 | 0.520 |
Why?
|
| Dietary Fats | 4 | 2010 | 271 | 0.510 |
Why?
|
| RNA, Messenger | 13 | 2016 | 2541 | 0.510 |
Why?
|
| Macrophage Activation | 2 | 2018 | 64 | 0.510 |
Why?
|
| Hyperglycemia | 4 | 2010 | 225 | 0.510 |
Why?
|
| Hypertension | 5 | 2018 | 1302 | 0.510 |
Why?
|
| Podocytes | 2 | 2014 | 74 | 0.500 |
Why?
|
| Cardiotonic Agents | 2 | 2009 | 135 | 0.500 |
Why?
|
| Thinness | 2 | 2014 | 69 | 0.500 |
Why?
|
| Streptococcus pyogenes | 1 | 2016 | 80 | 0.490 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2016 | 80 | 0.490 |
Why?
|
| Irritable Bowel Syndrome | 4 | 2020 | 213 | 0.490 |
Why?
|
| Bacteriological Techniques | 1 | 2016 | 85 | 0.490 |
Why?
|
| Oxides | 1 | 2016 | 16 | 0.490 |
Why?
|
| Macrophages, Peritoneal | 3 | 2012 | 36 | 0.490 |
Why?
|
| Angiogenic Proteins | 1 | 2016 | 15 | 0.490 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 414 | 0.480 |
Why?
|
| Bevacizumab | 1 | 2016 | 53 | 0.480 |
Why?
|
| Drug Monitoring | 1 | 2018 | 274 | 0.480 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2015 | 22 | 0.480 |
Why?
|
| Rats, Wistar | 11 | 2011 | 307 | 0.470 |
Why?
|
| Anticoagulants | 1 | 2020 | 581 | 0.470 |
Why?
|
| Retinopathy of Prematurity | 1 | 2016 | 50 | 0.470 |
Why?
|
| Laboratories | 3 | 2023 | 80 | 0.470 |
Why?
|
| Endosomes | 1 | 2015 | 62 | 0.470 |
Why?
|
| Cell Movement | 2 | 2016 | 851 | 0.460 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2016 | 106 | 0.460 |
Why?
|
| Algorithms | 2 | 2020 | 1635 | 0.460 |
Why?
|
| Diagnostic Errors | 2 | 2016 | 330 | 0.460 |
Why?
|
| Calcitonin | 1 | 2015 | 31 | 0.460 |
Why?
|
| Phytotherapy | 2 | 2012 | 45 | 0.460 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 790 | 0.450 |
Why?
|
| Energy Intake | 3 | 2008 | 495 | 0.450 |
Why?
|
| Microvessels | 3 | 2011 | 59 | 0.450 |
Why?
|
| Telemedicine | 1 | 2021 | 487 | 0.450 |
Why?
|
| Catechin | 2 | 2015 | 11 | 0.440 |
Why?
|
| Protein Kinase C-alpha | 3 | 2012 | 19 | 0.440 |
Why?
|
| Heart Transplantation | 1 | 2021 | 866 | 0.440 |
Why?
|
| Phenotype | 7 | 2023 | 4308 | 0.440 |
Why?
|
| Epigenesis, Genetic | 6 | 2021 | 711 | 0.440 |
Why?
|
| Metformin | 1 | 2016 | 159 | 0.440 |
Why?
|
| Protein Precursors | 1 | 2015 | 144 | 0.430 |
Why?
|
| Nephritis | 1 | 2014 | 20 | 0.430 |
Why?
|
| Sweat | 1 | 2014 | 7 | 0.430 |
Why?
|
| Signal Transduction | 12 | 2024 | 4485 | 0.430 |
Why?
|
| Risk Factors | 22 | 2021 | 10612 | 0.430 |
Why?
|
| Reagent Strips | 1 | 2014 | 11 | 0.420 |
Why?
|
| Bariatric Surgery | 1 | 2016 | 127 | 0.420 |
Why?
|
| Streptococcal Infections | 1 | 2016 | 247 | 0.420 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2014 | 16 | 0.420 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2013 | 76 | 0.420 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2014 | 33 | 0.420 |
Why?
|
| Dose-Response Relationship, Drug | 14 | 2024 | 1597 | 0.420 |
Why?
|
| Chlorides | 1 | 2014 | 98 | 0.420 |
Why?
|
| Saliva | 1 | 2014 | 130 | 0.420 |
Why?
|
| Coronary Artery Disease | 3 | 2011 | 848 | 0.410 |
Why?
|
| Specimen Handling | 1 | 2014 | 145 | 0.410 |
Why?
|
| Ascorbic Acid | 7 | 2016 | 70 | 0.410 |
Why?
|
| Alagille Syndrome | 2 | 2025 | 51 | 0.410 |
Why?
|
| Kidney | 3 | 2017 | 1283 | 0.410 |
Why?
|
| Disease Models, Animal | 16 | 2024 | 4446 | 0.410 |
Why?
|
| Waist Circumference | 6 | 2019 | 92 | 0.410 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2016 | 332 | 0.410 |
Why?
|
| Chemokine CCL2 | 5 | 2012 | 111 | 0.410 |
Why?
|
| Self-Management | 2 | 2026 | 111 | 0.410 |
Why?
|
| Albuminuria | 1 | 2014 | 104 | 0.400 |
Why?
|
| Up-Regulation | 9 | 2018 | 827 | 0.400 |
Why?
|
| Immunoglobulins, Thyroid-Stimulating | 1 | 2013 | 3 | 0.400 |
Why?
|
| Graves Disease | 1 | 2013 | 13 | 0.390 |
Why?
|
| Clinical Competence | 1 | 2020 | 1020 | 0.390 |
Why?
|
| Transition to Adult Care | 2 | 2026 | 122 | 0.390 |
Why?
|
| Mice, Inbred C57BL | 14 | 2022 | 4513 | 0.390 |
Why?
|
| Chemokines | 6 | 2019 | 127 | 0.390 |
Why?
|
| Vitamin B 12 | 3 | 2010 | 57 | 0.390 |
Why?
|
| Oligoribonucleotides, Antisense | 1 | 2012 | 2 | 0.380 |
Why?
|
| Systemic Inflammatory Response Syndrome | 2 | 2025 | 200 | 0.380 |
Why?
|
| Hypoglycemia | 1 | 2014 | 176 | 0.380 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 1759 | 0.370 |
Why?
|
| Hospitals | 1 | 2015 | 428 | 0.370 |
Why?
|
| Glucuronidase | 1 | 2012 | 29 | 0.370 |
Why?
|
| Caveolin 1 | 2 | 2011 | 50 | 0.370 |
Why?
|
| Mice, Knockout | 10 | 2024 | 3718 | 0.370 |
Why?
|
| Sirtuin 1 | 2 | 2013 | 56 | 0.370 |
Why?
|
| Apolipoproteins B | 5 | 2013 | 139 | 0.370 |
Why?
|
| Cholestasis | 2 | 2025 | 166 | 0.360 |
Why?
|
| Prediabetic State | 1 | 2012 | 65 | 0.360 |
Why?
|
| Hypersensitivity | 1 | 2014 | 225 | 0.360 |
Why?
|
| Metagenome | 1 | 2013 | 142 | 0.360 |
Why?
|
| Ethylene Glycol | 1 | 2011 | 1 | 0.360 |
Why?
|
| Enzyme Assays | 1 | 2011 | 11 | 0.360 |
Why?
|
| Cell-Derived Microparticles | 1 | 2011 | 27 | 0.360 |
Why?
|
| Hospitals, Pediatric | 5 | 2018 | 775 | 0.360 |
Why?
|
| Poisoning | 1 | 2011 | 16 | 0.350 |
Why?
|
| Vitamin E | 5 | 2005 | 63 | 0.350 |
Why?
|
| Protein Kinase C | 5 | 2008 | 111 | 0.350 |
Why?
|
| Stilbenes | 1 | 2011 | 37 | 0.350 |
Why?
|
| RNA, Long Noncoding | 3 | 2021 | 228 | 0.350 |
Why?
|
| Drugs, Investigational | 1 | 2011 | 25 | 0.350 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2011 | 37 | 0.350 |
Why?
|
| Feces | 6 | 2023 | 702 | 0.340 |
Why?
|
| Pilot Projects | 8 | 2024 | 1400 | 0.340 |
Why?
|
| Stem Cell Factor | 1 | 2010 | 11 | 0.340 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2013 | 342 | 0.330 |
Why?
|
| Chemokine CXCL12 | 1 | 2010 | 34 | 0.330 |
Why?
|
| Genotype | 1 | 2016 | 2598 | 0.330 |
Why?
|
| Gene Expression Regulation | 8 | 2018 | 2312 | 0.330 |
Why?
|
| Cell Proliferation | 3 | 2013 | 2398 | 0.330 |
Why?
|
| Phagocytosis | 4 | 2024 | 191 | 0.330 |
Why?
|
| Autoantibodies | 4 | 2024 | 423 | 0.330 |
Why?
|
| Camellia sinensis | 1 | 2010 | 4 | 0.330 |
Why?
|
| Carotenoids | 2 | 2008 | 77 | 0.320 |
Why?
|
| Curcumin | 1 | 2010 | 43 | 0.320 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2010 | 92 | 0.320 |
Why?
|
| Aging | 4 | 2022 | 1198 | 0.320 |
Why?
|
| Vitamin D Deficiency | 1 | 2011 | 73 | 0.320 |
Why?
|
| Malondialdehyde | 3 | 2021 | 49 | 0.320 |
Why?
|
| Stress, Psychological | 2 | 2025 | 547 | 0.320 |
Why?
|
| Pediatric Obesity | 2 | 2016 | 409 | 0.320 |
Why?
|
| Quality Improvement | 3 | 2024 | 684 | 0.310 |
Why?
|
| RNA, Small Interfering | 7 | 2011 | 658 | 0.310 |
Why?
|
| Glycocalyx | 1 | 2009 | 4 | 0.310 |
Why?
|
| Flow Cytometry | 7 | 2015 | 755 | 0.310 |
Why?
|
| Flavonoids | 4 | 2005 | 81 | 0.310 |
Why?
|
| ROC Curve | 4 | 2024 | 587 | 0.310 |
Why?
|
| Hemolysis | 2 | 2023 | 103 | 0.300 |
Why?
|
| Arachis | 2 | 2021 | 75 | 0.300 |
Why?
|
| Fibroblast Growth Factors | 1 | 2010 | 162 | 0.300 |
Why?
|
| Abdominal Pain | 4 | 2020 | 308 | 0.300 |
Why?
|
| Pregnancy | 8 | 2025 | 7402 | 0.300 |
Why?
|
| Chemokine CXCL10 | 1 | 2009 | 51 | 0.300 |
Why?
|
| Microscopy, Video | 1 | 2009 | 19 | 0.300 |
Why?
|
| Intestinal Mucosa | 4 | 2020 | 754 | 0.300 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2013 | 517 | 0.300 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2008 | 16 | 0.300 |
Why?
|
| Administration, Oral | 7 | 2021 | 685 | 0.300 |
Why?
|
| Intestines | 1 | 2013 | 578 | 0.290 |
Why?
|
| Mice | 24 | 2024 | 17686 | 0.290 |
Why?
|
| Ghrelin | 2 | 2020 | 57 | 0.290 |
Why?
|
| Foam Cells | 1 | 2008 | 21 | 0.290 |
Why?
|
| Infant, Premature | 3 | 2022 | 826 | 0.290 |
Why?
|
| Peanut Hypersensitivity | 2 | 2021 | 86 | 0.290 |
Why?
|
| Persian Gulf Syndrome | 2 | 2021 | 16 | 0.290 |
Why?
|
| Thromboplastin | 1 | 2008 | 19 | 0.290 |
Why?
|
| Adjuvants, Immunologic | 1 | 2010 | 380 | 0.280 |
Why?
|
| Body Mass Index | 6 | 2019 | 1659 | 0.280 |
Why?
|
| Sitosterols | 2 | 2006 | 10 | 0.280 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2010 | 219 | 0.280 |
Why?
|
| Blotting, Western | 8 | 2010 | 1015 | 0.270 |
Why?
|
| Genetic Therapy | 1 | 2012 | 683 | 0.270 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 4 | 2010 | 68 | 0.270 |
Why?
|
| Cholesterol, Dietary | 2 | 2006 | 48 | 0.270 |
Why?
|
| Placebos | 5 | 2016 | 226 | 0.270 |
Why?
|
| Kidney Failure, Chronic | 3 | 2012 | 924 | 0.270 |
Why?
|
| Myeloid Differentiation Factor 88 | 4 | 2013 | 95 | 0.260 |
Why?
|
| Oxidation-Reduction | 4 | 2006 | 424 | 0.260 |
Why?
|
| Sepsis | 2 | 2024 | 494 | 0.260 |
Why?
|
| Self Care | 2 | 2026 | 228 | 0.260 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2024 | 225 | 0.260 |
Why?
|
| Microcirculation | 1 | 2007 | 102 | 0.260 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 2519 | 0.260 |
Why?
|
| Angina, Unstable | 1 | 2006 | 49 | 0.260 |
Why?
|
| Oxygen | 2 | 2020 | 541 | 0.260 |
Why?
|
| Infant, Newborn | 10 | 2025 | 8366 | 0.260 |
Why?
|
| Stem Cells | 1 | 2011 | 682 | 0.260 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2006 | 260 | 0.250 |
Why?
|
| Isoproterenol | 4 | 2009 | 89 | 0.250 |
Why?
|
| Allylamine | 1 | 2006 | 8 | 0.250 |
Why?
|
| Carotid Artery Diseases | 1 | 2007 | 133 | 0.250 |
Why?
|
| Plant Bark | 2 | 2003 | 4 | 0.250 |
Why?
|
| Biopsy | 3 | 2026 | 1237 | 0.240 |
Why?
|
| Severity of Illness Index | 7 | 2025 | 2995 | 0.240 |
Why?
|
| Fetal Hemoglobin | 2 | 2019 | 26 | 0.240 |
Why?
|
| Treatment Outcome | 13 | 2025 | 12572 | 0.240 |
Why?
|
| Bronchopulmonary Dysplasia | 2 | 2022 | 211 | 0.240 |
Why?
|
| Weight Loss | 3 | 2006 | 503 | 0.240 |
Why?
|
| Adipokines | 3 | 2018 | 118 | 0.240 |
Why?
|
| Kidney Diseases | 1 | 2010 | 482 | 0.240 |
Why?
|
| Vaccination | 2 | 2025 | 1004 | 0.240 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 2005 | 3 | 0.230 |
Why?
|
| Cell Line | 8 | 2015 | 2565 | 0.230 |
Why?
|
| Streptozocin | 3 | 2018 | 26 | 0.230 |
Why?
|
| Iron | 3 | 2025 | 299 | 0.230 |
Why?
|
| Plants, Medicinal | 2 | 1996 | 25 | 0.230 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 2025 | 19 | 0.230 |
Why?
|
| Immunoenzyme Techniques | 1 | 2025 | 237 | 0.230 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2021 | 333 | 0.230 |
Why?
|
| Prospective Studies | 11 | 2024 | 6241 | 0.230 |
Why?
|
| Myocardium | 2 | 2007 | 845 | 0.230 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2025 | 50 | 0.230 |
Why?
|
| Liver Diseases, Alcoholic | 3 | 2011 | 59 | 0.230 |
Why?
|
| Basal Ganglia | 1 | 2025 | 58 | 0.230 |
Why?
|
| Anemia, Iron-Deficiency | 2 | 2025 | 138 | 0.220 |
Why?
|
| Portoenterostomy, Hepatic | 1 | 2025 | 59 | 0.220 |
Why?
|
| beta-Thalassemia | 1 | 2024 | 26 | 0.220 |
Why?
|
| Typhus, Endemic Flea-Borne | 1 | 2025 | 28 | 0.220 |
Why?
|
| Down-Regulation | 6 | 2021 | 649 | 0.220 |
Why?
|
| Texas | 3 | 2020 | 3565 | 0.220 |
Why?
|
| Jaundice | 2 | 2015 | 27 | 0.220 |
Why?
|
| Fluoxetine | 1 | 2024 | 44 | 0.220 |
Why?
|
| Acetylcysteine | 1 | 2025 | 79 | 0.220 |
Why?
|
| Point-of-Care Systems | 2 | 2020 | 197 | 0.220 |
Why?
|
| Body Height | 2 | 2024 | 192 | 0.220 |
Why?
|
| Sertraline | 1 | 2024 | 44 | 0.220 |
Why?
|
| Metabolomics | 2 | 2018 | 455 | 0.220 |
Why?
|
| Affect | 1 | 2025 | 167 | 0.210 |
Why?
|
| Interleukin-1 | 3 | 2012 | 131 | 0.210 |
Why?
|
| Stigmasterol | 1 | 2004 | 2 | 0.210 |
Why?
|
| Citrus | 1 | 2004 | 5 | 0.210 |
Why?
|
| Fatty Acids | 1 | 2006 | 351 | 0.210 |
Why?
|
| Elasticity Imaging Techniques | 2 | 2025 | 145 | 0.210 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2025 | 236 | 0.210 |
Why?
|
| Human Growth Hormone | 1 | 2024 | 75 | 0.210 |
Why?
|
| Community Health Centers | 1 | 2024 | 37 | 0.210 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 3 | 2019 | 119 | 0.210 |
Why?
|
| Atovaquone | 1 | 2024 | 10 | 0.210 |
Why?
|
| Immune System | 3 | 2020 | 93 | 0.210 |
Why?
|
| Puberty | 1 | 2024 | 103 | 0.210 |
Why?
|
| Terminalia | 1 | 2003 | 2 | 0.210 |
Why?
|
| Leukocytes | 1 | 2005 | 204 | 0.210 |
Why?
|
| Grape Seed Extract | 3 | 2009 | 4 | 0.210 |
Why?
|
| Food, Fortified | 1 | 2004 | 62 | 0.210 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2023 | 7 | 0.210 |
Why?
|
| Pathologists | 1 | 2023 | 26 | 0.210 |
Why?
|
| Calcifediol | 1 | 2023 | 13 | 0.210 |
Why?
|
| Peer Group | 1 | 2024 | 121 | 0.210 |
Why?
|
| Time Factors | 10 | 2020 | 6163 | 0.200 |
Why?
|
| Mortality | 1 | 2005 | 254 | 0.200 |
Why?
|
| Benzaldehydes | 1 | 2023 | 13 | 0.200 |
Why?
|
| Lipid Peroxidation | 6 | 2008 | 90 | 0.200 |
Why?
|
| Immunoglobulins | 2 | 2014 | 156 | 0.200 |
Why?
|
| Antibodies | 4 | 2011 | 352 | 0.200 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2005 | 293 | 0.200 |
Why?
|
| Blastocystis Infections | 1 | 2023 | 5 | 0.200 |
Why?
|
| Blastocystis | 1 | 2023 | 6 | 0.200 |
Why?
|
| United States | 7 | 2021 | 11386 | 0.200 |
Why?
|
| Social Support | 1 | 2026 | 368 | 0.200 |
Why?
|
| Resilience, Psychological | 1 | 2024 | 77 | 0.200 |
Why?
|
| P-Selectin | 2 | 2008 | 68 | 0.200 |
Why?
|
| Blood Coagulation Disorders | 1 | 2004 | 105 | 0.200 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 3 | 2009 | 20 | 0.200 |
Why?
|
| Age Factors | 3 | 2021 | 2803 | 0.200 |
Why?
|
| Proteome | 2 | 2025 | 274 | 0.200 |
Why?
|
| Pinus | 1 | 2002 | 1 | 0.200 |
Why?
|
| Hepatic Stellate Cells | 3 | 2012 | 28 | 0.200 |
Why?
|
| Mentors | 1 | 2024 | 154 | 0.190 |
Why?
|
| Pyrazines | 1 | 2023 | 77 | 0.190 |
Why?
|
| Cadherins | 1 | 2024 | 174 | 0.190 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2024 | 317 | 0.190 |
Why?
|
| Sleep Wake Disorders | 1 | 2025 | 189 | 0.190 |
Why?
|
| Anemia | 2 | 2023 | 339 | 0.190 |
Why?
|
| Platelet Aggregation | 1 | 2003 | 107 | 0.190 |
Why?
|
| Homocysteine | 4 | 2010 | 118 | 0.190 |
Why?
|
| Follow-Up Studies | 4 | 2014 | 5150 | 0.190 |
Why?
|
| Membrane Glycoproteins | 3 | 2015 | 416 | 0.190 |
Why?
|
| Cell Nucleus | 2 | 2018 | 551 | 0.190 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2003 | 124 | 0.190 |
Why?
|
| Blood Gas Analysis | 2 | 2020 | 88 | 0.190 |
Why?
|
| Peptide Fragments | 2 | 2024 | 756 | 0.190 |
Why?
|
| Heparin | 2 | 2020 | 206 | 0.190 |
Why?
|
| In Vitro Techniques | 4 | 2013 | 825 | 0.190 |
Why?
|
| Phenols | 1 | 2002 | 66 | 0.190 |
Why?
|
| Xenon | 1 | 2022 | 10 | 0.180 |
Why?
|
| Dietary Fiber | 3 | 2016 | 78 | 0.180 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2010 | 1232 | 0.180 |
Why?
|
| Receptors, Ghrelin | 1 | 2022 | 29 | 0.180 |
Why?
|
| F2-Isoprostanes | 5 | 2008 | 20 | 0.180 |
Why?
|
| Cell Count | 2 | 2013 | 218 | 0.180 |
Why?
|
| Histone Deacetylases | 3 | 2015 | 113 | 0.180 |
Why?
|
| Asparaginase | 1 | 2022 | 49 | 0.180 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2024 | 321 | 0.180 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2013 | 276 | 0.180 |
Why?
|
| Neonatal Screening | 2 | 2014 | 190 | 0.180 |
Why?
|
| Apolipoproteins | 1 | 2002 | 70 | 0.180 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2006 | 116 | 0.180 |
Why?
|
| Glycolysis | 2 | 2020 | 169 | 0.180 |
Why?
|
| Hemodiafiltration | 1 | 2021 | 16 | 0.180 |
Why?
|
| Models, Biological | 6 | 2008 | 1374 | 0.180 |
Why?
|
| Ubiquinone | 2 | 2014 | 25 | 0.180 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 3 | 2011 | 21 | 0.180 |
Why?
|
| Electrophoresis, Capillary | 1 | 2021 | 11 | 0.180 |
Why?
|
| Ovarian Hyperstimulation Syndrome | 1 | 2021 | 12 | 0.180 |
Why?
|
| Pesticides | 1 | 2021 | 28 | 0.180 |
Why?
|
| Antifungal Agents | 1 | 2024 | 296 | 0.170 |
Why?
|
| Hematologic Tests | 1 | 2021 | 36 | 0.170 |
Why?
|
| Sex Characteristics | 2 | 2020 | 314 | 0.170 |
Why?
|
| Hematocrit | 2 | 2020 | 110 | 0.170 |
Why?
|
| Diet, Atherogenic | 3 | 2010 | 14 | 0.170 |
Why?
|
| Dendritic Cells | 1 | 2024 | 435 | 0.170 |
Why?
|
| Renal Insufficiency | 2 | 2020 | 249 | 0.170 |
Why?
|
| Metabolome | 2 | 2021 | 316 | 0.170 |
Why?
|
| Antibody Formation | 1 | 2021 | 267 | 0.170 |
Why?
|
| Diet | 4 | 2017 | 1102 | 0.170 |
Why?
|
| beta-Defensins | 1 | 2020 | 12 | 0.170 |
Why?
|
| Reproduction | 1 | 2022 | 214 | 0.170 |
Why?
|
| Sodium Fluoride | 1 | 2020 | 7 | 0.170 |
Why?
|
| Lactulose | 2 | 2019 | 27 | 0.170 |
Why?
|
| Incidence | 3 | 2021 | 3261 | 0.170 |
Why?
|
| Polyethylene Glycols | 1 | 2022 | 240 | 0.170 |
Why?
|
| Endocrinologists | 1 | 2020 | 1 | 0.170 |
Why?
|
| Perioperative Period | 1 | 2020 | 51 | 0.160 |
Why?
|
| Desensitization, Immunologic | 2 | 2021 | 113 | 0.160 |
Why?
|
| Liver Diseases | 2 | 2022 | 381 | 0.160 |
Why?
|
| Ovarian Follicle | 1 | 2021 | 119 | 0.160 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2025 | 483 | 0.160 |
Why?
|
| Serologic Tests | 1 | 2020 | 122 | 0.160 |
Why?
|
| Thyrotropin | 1 | 2020 | 53 | 0.160 |
Why?
|
| Factor VIII | 1 | 2020 | 47 | 0.160 |
Why?
|
| Colitis | 1 | 2022 | 156 | 0.160 |
Why?
|
| Fertility | 1 | 2022 | 251 | 0.160 |
Why?
|
| Workload | 1 | 2021 | 150 | 0.160 |
Why?
|
| Blood | 1 | 2020 | 99 | 0.160 |
Why?
|
| RNA-Binding Proteins | 2 | 2021 | 532 | 0.160 |
Why?
|
| S-Adenosylmethionine | 2 | 2011 | 27 | 0.160 |
Why?
|
| Bifidobacterium | 1 | 2020 | 66 | 0.160 |
Why?
|
| Veins | 1 | 2020 | 99 | 0.160 |
Why?
|
| Thyroxine | 1 | 2020 | 62 | 0.160 |
Why?
|
| Patient Admission | 1 | 2021 | 181 | 0.150 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2024 | 422 | 0.150 |
Why?
|
| Thyroid Gland | 1 | 2020 | 99 | 0.150 |
Why?
|
| Energy Metabolism | 3 | 2022 | 761 | 0.150 |
Why?
|
| Lipopolysaccharide Receptors | 2 | 2016 | 53 | 0.150 |
Why?
|
| Overweight | 2 | 2020 | 372 | 0.150 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2019 | 36 | 0.150 |
Why?
|
| Reactive Oxygen Species | 4 | 2012 | 493 | 0.150 |
Why?
|
| Serotonin | 1 | 2020 | 203 | 0.150 |
Why?
|
| Methionine | 4 | 2013 | 90 | 0.150 |
Why?
|
| Infant Formula | 1 | 2020 | 104 | 0.150 |
Why?
|
| Enzyme Induction | 2 | 2012 | 97 | 0.150 |
Why?
|
| Muscular Atrophy | 1 | 2020 | 74 | 0.150 |
Why?
|
| Myeloid Cells | 2 | 2024 | 106 | 0.150 |
Why?
|
| Emergency Service, Hospital | 2 | 2018 | 1178 | 0.150 |
Why?
|
| Costs and Cost Analysis | 1 | 2020 | 155 | 0.150 |
Why?
|
| Oximetry | 1 | 2020 | 174 | 0.150 |
Why?
|
| Biological Availability | 3 | 2010 | 137 | 0.150 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2018 | 382 | 0.150 |
Why?
|
| Resistin | 2 | 2016 | 30 | 0.150 |
Why?
|
| Kidney Function Tests | 1 | 2019 | 133 | 0.150 |
Why?
|
| Cross-Sectional Studies | 6 | 2025 | 3683 | 0.150 |
Why?
|
| Dimensional Measurement Accuracy | 1 | 2018 | 4 | 0.150 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2025 | 887 | 0.150 |
Why?
|
| Circadian Clocks | 1 | 2020 | 82 | 0.150 |
Why?
|
| Bicarbonates | 1 | 2019 | 98 | 0.150 |
Why?
|
| Epitopes | 1 | 2020 | 420 | 0.150 |
Why?
|
| Nomograms | 1 | 2019 | 35 | 0.150 |
Why?
|
| Gestational Age | 3 | 2022 | 1188 | 0.150 |
Why?
|
| Hepatocytes | 2 | 2012 | 231 | 0.150 |
Why?
|
| Resuscitation | 1 | 2021 | 267 | 0.150 |
Why?
|
| Lutein | 2 | 2010 | 14 | 0.150 |
Why?
|
| Receptors, LDL | 2 | 2014 | 106 | 0.150 |
Why?
|
| Autonomic Nervous System | 1 | 2018 | 46 | 0.140 |
Why?
|
| Hypoxia | 1 | 2020 | 243 | 0.140 |
Why?
|
| Pasteurellaceae | 1 | 2018 | 4 | 0.140 |
Why?
|
| Clostridiaceae | 1 | 2018 | 5 | 0.140 |
Why?
|
| Mast Cells | 1 | 2019 | 67 | 0.140 |
Why?
|
| Transfection | 3 | 2009 | 948 | 0.140 |
Why?
|
| Actinomycetaceae | 1 | 2018 | 6 | 0.140 |
Why?
|
| Eosinophils | 1 | 2019 | 123 | 0.140 |
Why?
|
| Forkhead Transcription Factors | 2 | 2011 | 363 | 0.140 |
Why?
|
| Cell Culture Techniques | 4 | 2020 | 270 | 0.140 |
Why?
|
| Argininosuccinic Aciduria | 1 | 2018 | 55 | 0.140 |
Why?
|
| Disease Progression | 4 | 2018 | 2120 | 0.140 |
Why?
|
| Lipopolysaccharides | 6 | 2009 | 291 | 0.140 |
Why?
|
| Aldehydes | 2 | 2008 | 28 | 0.140 |
Why?
|
| Bacteroidetes | 1 | 2017 | 23 | 0.140 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2017 | 54 | 0.140 |
Why?
|
| Molecular Typing | 1 | 2017 | 32 | 0.140 |
Why?
|
| Serum Amyloid A Protein | 1 | 2017 | 22 | 0.140 |
Why?
|
| Argininosuccinate Lyase | 1 | 2018 | 65 | 0.140 |
Why?
|
| Fetal Blood | 1 | 2019 | 173 | 0.140 |
Why?
|
| Thrombosis | 4 | 2008 | 503 | 0.140 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2020 | 477 | 0.140 |
Why?
|
| Quality of Life | 2 | 2024 | 2029 | 0.140 |
Why?
|
| Automation, Laboratory | 1 | 2017 | 16 | 0.140 |
Why?
|
| HMGB1 Protein | 2 | 2015 | 25 | 0.130 |
Why?
|
| High Fructose Corn Syrup | 1 | 2017 | 6 | 0.130 |
Why?
|
| Binding, Competitive | 1 | 2017 | 153 | 0.130 |
Why?
|
| Sucrose | 1 | 2017 | 35 | 0.130 |
Why?
|
| Primary Prevention | 1 | 2019 | 173 | 0.130 |
Why?
|
| Secondary Prevention | 1 | 2019 | 218 | 0.130 |
Why?
|
| Pyridines | 2 | 2012 | 251 | 0.130 |
Why?
|
| Interleukin-18 | 1 | 2017 | 77 | 0.130 |
Why?
|
| Guideline Adherence | 1 | 2020 | 384 | 0.130 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 148 | 0.130 |
Why?
|
| Milk, Human | 1 | 2020 | 308 | 0.130 |
Why?
|
| Renal Dialysis | 3 | 2021 | 936 | 0.130 |
Why?
|
| Interleukin-10 | 2 | 2010 | 181 | 0.130 |
Why?
|
| Scurvy | 1 | 2016 | 2 | 0.130 |
Why?
|
| Blood Pressure | 3 | 2018 | 1312 | 0.130 |
Why?
|
| Anti-HIV Agents | 2 | 2012 | 346 | 0.130 |
Why?
|
| Fibrosis | 2 | 2019 | 400 | 0.130 |
Why?
|
| Isoelectric Focusing | 1 | 2016 | 23 | 0.130 |
Why?
|
| Mannitol | 1 | 2016 | 40 | 0.130 |
Why?
|
| Tocopherols | 3 | 2007 | 6 | 0.130 |
Why?
|
| Albendazole | 1 | 2016 | 27 | 0.130 |
Why?
|
| Clinical Trials as Topic | 3 | 2013 | 1110 | 0.130 |
Why?
|
| Haptoglobins | 2 | 2014 | 14 | 0.130 |
Why?
|
| Pharynx | 1 | 2016 | 64 | 0.130 |
Why?
|
| Brain Injuries | 1 | 2022 | 693 | 0.120 |
Why?
|
| Child Nutrition Disorders | 1 | 2016 | 41 | 0.120 |
Why?
|
| Micronutrients | 1 | 2016 | 60 | 0.120 |
Why?
|
| Depression | 1 | 2025 | 1294 | 0.120 |
Why?
|
| Psyllium | 1 | 2016 | 13 | 0.120 |
Why?
|
| Enteritis | 1 | 2016 | 52 | 0.120 |
Why?
|
| Insulin | 6 | 2017 | 1128 | 0.120 |
Why?
|
| Intravitreal Injections | 1 | 2016 | 39 | 0.120 |
Why?
|
| Zinc | 1 | 2016 | 121 | 0.120 |
Why?
|
| Intestinal Diseases | 1 | 2016 | 68 | 0.120 |
Why?
|
| Schizophrenia | 1 | 2019 | 320 | 0.120 |
Why?
|
| Injections, Intraperitoneal | 2 | 2013 | 66 | 0.120 |
Why?
|
| Rats, Inbred BB | 2 | 2013 | 4 | 0.120 |
Why?
|
| Bacteria | 2 | 2023 | 515 | 0.120 |
Why?
|
| Fibrinolysis | 3 | 2011 | 43 | 0.120 |
Why?
|
| Fatty Acids, Nonesterified | 3 | 2014 | 112 | 0.120 |
Why?
|
| Amino Acids | 2 | 2021 | 615 | 0.120 |
Why?
|
| Kinetics | 1 | 2017 | 1092 | 0.120 |
Why?
|
| HIV Infections | 3 | 2014 | 1954 | 0.120 |
Why?
|
| alpha-2-HS-Glycoprotein | 1 | 2015 | 8 | 0.120 |
Why?
|
| Pertussis Vaccine | 1 | 2015 | 26 | 0.120 |
Why?
|
| Basement Membrane | 1 | 2015 | 38 | 0.120 |
Why?
|
| Growth Disorders | 1 | 2016 | 183 | 0.120 |
Why?
|
| Intestinal Absorption | 2 | 2006 | 170 | 0.120 |
Why?
|
| Postprandial Period | 3 | 2010 | 85 | 0.110 |
Why?
|
| Permeability | 3 | 2019 | 116 | 0.110 |
Why?
|
| Lower Extremity | 1 | 2016 | 180 | 0.110 |
Why?
|
| Lupus Nephritis | 1 | 2015 | 41 | 0.110 |
Why?
|
| Sialorrhea | 1 | 2014 | 16 | 0.110 |
Why?
|
| Food Hypersensitivity | 1 | 2018 | 177 | 0.110 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2015 | 85 | 0.110 |
Why?
|
| Diagnostic Imaging | 1 | 2016 | 289 | 0.110 |
Why?
|
| Pterins | 2 | 2011 | 6 | 0.110 |
Why?
|
| Complement System Proteins | 1 | 2014 | 57 | 0.110 |
Why?
|
| Interferon Regulatory Factor-3 | 2 | 2011 | 18 | 0.110 |
Why?
|
| Epoprostenol | 2 | 2005 | 43 | 0.110 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2014 | 24 | 0.110 |
Why?
|
| Pilocarpine | 1 | 2014 | 11 | 0.110 |
Why?
|
| Iontophoresis | 1 | 2014 | 6 | 0.110 |
Why?
|
| Birth Weight | 1 | 2016 | 340 | 0.110 |
Why?
|
| Scavenger Receptors, Class E | 2 | 2011 | 8 | 0.110 |
Why?
|
| Metabolic Diseases | 1 | 2015 | 132 | 0.110 |
Why?
|
| Histone Acetyltransferases | 2 | 2015 | 224 | 0.110 |
Why?
|
| Clostridium Infections | 1 | 2017 | 242 | 0.110 |
Why?
|
| Microbiota | 2 | 2022 | 426 | 0.110 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 2 | 2011 | 48 | 0.110 |
Why?
|
| Hyperhomocysteinemia | 2 | 2004 | 37 | 0.100 |
Why?
|
| HIV Enteropathy | 1 | 2013 | 2 | 0.100 |
Why?
|
| Serum Globulins | 1 | 2013 | 7 | 0.100 |
Why?
|
| Adsorption | 1 | 2013 | 34 | 0.100 |
Why?
|
| Risk | 3 | 2013 | 736 | 0.100 |
Why?
|
| Coronary Disease | 2 | 2007 | 640 | 0.100 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2014 | 131 | 0.100 |
Why?
|
| Glycation End Products, Advanced | 1 | 2013 | 25 | 0.100 |
Why?
|
| Immunity, Mucosal | 1 | 2013 | 83 | 0.100 |
Why?
|
| Transcription Factor RelA | 2 | 2010 | 49 | 0.100 |
Why?
|
| Antibodies, Bacterial | 1 | 2015 | 401 | 0.100 |
Why?
|
| ADAM Proteins | 1 | 2013 | 83 | 0.100 |
Why?
|
| Reference Standards | 1 | 2014 | 230 | 0.100 |
Why?
|
| Thiocyanates | 1 | 2012 | 5 | 0.100 |
Why?
|
| Lectins | 1 | 2013 | 49 | 0.100 |
Why?
|
| Carbohydrate Metabolism | 1 | 2013 | 51 | 0.100 |
Why?
|
| Duodenum | 1 | 2013 | 110 | 0.100 |
Why?
|
| Brassica | 1 | 2012 | 17 | 0.100 |
Why?
|
| Phospholipids | 3 | 2007 | 99 | 0.100 |
Why?
|
| Trachea | 1 | 2014 | 204 | 0.100 |
Why?
|
| Age of Onset | 1 | 2014 | 611 | 0.100 |
Why?
|
| Psoriasis | 1 | 2013 | 52 | 0.100 |
Why?
|
| Immune Reconstitution Inflammatory Syndrome | 1 | 2012 | 18 | 0.100 |
Why?
|
| Docosahexaenoic Acids | 1 | 2013 | 65 | 0.100 |
Why?
|
| Immunotherapy | 1 | 2018 | 742 | 0.090 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2012 | 12 | 0.090 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2013 | 81 | 0.090 |
Why?
|
| Allergens | 3 | 2021 | 346 | 0.090 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2012 | 52 | 0.090 |
Why?
|
| Nitroso Compounds | 1 | 2011 | 7 | 0.090 |
Why?
|
| Tyrosine | 3 | 2012 | 146 | 0.090 |
Why?
|
| Alleles | 1 | 2016 | 1609 | 0.090 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2012 | 50 | 0.090 |
Why?
|
| Hyaluronic Acid | 2 | 2010 | 102 | 0.090 |
Why?
|
| Galectin 3 | 1 | 2011 | 31 | 0.090 |
Why?
|
| Probiotics | 1 | 2014 | 222 | 0.090 |
Why?
|
| Vasodilation | 2 | 2010 | 173 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 66 | 0.090 |
Why?
|
| Antigens, CD34 | 1 | 2011 | 99 | 0.090 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2011 | 31 | 0.090 |
Why?
|
| Culture Media, Conditioned | 2 | 2008 | 82 | 0.090 |
Why?
|
| Oxazolidinones | 1 | 2011 | 32 | 0.090 |
Why?
|
| Fluorobenzenes | 1 | 2011 | 39 | 0.090 |
Why?
|
| Preventive Medicine | 1 | 2011 | 18 | 0.090 |
Why?
|
| Intubation, Intratracheal | 1 | 2014 | 285 | 0.090 |
Why?
|
| Prognosis | 5 | 2017 | 4800 | 0.080 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 650 | 0.080 |
Why?
|
| Antigens, Surface | 1 | 2011 | 114 | 0.080 |
Why?
|
| Serum Albumin | 1 | 2011 | 110 | 0.080 |
Why?
|
| Interleukin-4 | 1 | 2011 | 144 | 0.080 |
Why?
|
| CD18 Antigens | 1 | 2010 | 43 | 0.080 |
Why?
|
| Enzyme Inhibitors | 4 | 2008 | 563 | 0.080 |
Why?
|
| Histone Deacetylase 2 | 1 | 2010 | 15 | 0.080 |
Why?
|
| CD11c Antigen | 1 | 2010 | 40 | 0.080 |
Why?
|
| Polymyxin B | 1 | 2011 | 46 | 0.080 |
Why?
|
| Cell Polarity | 1 | 2011 | 116 | 0.080 |
Why?
|
| Quinolines | 1 | 2011 | 112 | 0.080 |
Why?
|
| Healthy Volunteers | 2 | 2021 | 148 | 0.080 |
Why?
|
| Gels | 1 | 2010 | 69 | 0.080 |
Why?
|
| Plant Leaves | 1 | 2010 | 54 | 0.080 |
Why?
|
| Glycemic Index | 1 | 2010 | 20 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2015 | 1011 | 0.080 |
Why?
|
| Cross Reactions | 1 | 2010 | 181 | 0.080 |
Why?
|
| Lipoproteins, VLDL | 2 | 2003 | 53 | 0.080 |
Why?
|
| CD40 Ligand | 2 | 2008 | 63 | 0.080 |
Why?
|
| Fruit | 1 | 2011 | 231 | 0.080 |
Why?
|
| Immunoglobulin A | 2 | 2024 | 205 | 0.080 |
Why?
|
| Protein Isoforms | 1 | 2010 | 405 | 0.080 |
Why?
|
| I-kappa B Kinase | 1 | 2009 | 56 | 0.080 |
Why?
|
| Enzyme Activation | 2 | 2008 | 578 | 0.080 |
Why?
|
| Sulfonamides | 1 | 2011 | 280 | 0.080 |
Why?
|
| Goblet Cells | 1 | 2010 | 101 | 0.080 |
Why?
|
| Postmenopause | 1 | 2010 | 141 | 0.070 |
Why?
|
| Glucose Intolerance | 1 | 2010 | 83 | 0.070 |
Why?
|
| Pyrroles | 2 | 2008 | 184 | 0.070 |
Why?
|
| Prostaglandins F | 2 | 2006 | 9 | 0.070 |
Why?
|
| Models, Immunological | 1 | 2008 | 37 | 0.070 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 412 | 0.070 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2007 | 64 | 0.070 |
Why?
|
| Peroxidase | 1 | 2008 | 62 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 720 | 0.070 |
Why?
|
| Integrin alpha4beta1 | 1 | 2008 | 26 | 0.070 |
Why?
|
| Thiazolidinediones | 1 | 2009 | 79 | 0.070 |
Why?
|
| CD40 Antigens | 1 | 2008 | 24 | 0.070 |
Why?
|
| Coagulants | 1 | 2008 | 8 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 1 | 2011 | 380 | 0.070 |
Why?
|
| CD11b Antigen | 1 | 2008 | 35 | 0.070 |
Why?
|
| Comet Assay | 1 | 2008 | 7 | 0.070 |
Why?
|
| Adenylate Kinase | 1 | 2008 | 12 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2020 | 3074 | 0.070 |
Why?
|
| Isoenzymes | 3 | 2010 | 213 | 0.070 |
Why?
|
| I-kappa B Proteins | 1 | 2008 | 38 | 0.070 |
Why?
|
| Deoxyguanosine | 1 | 2008 | 12 | 0.070 |
Why?
|
| STAT Transcription Factors | 1 | 2008 | 25 | 0.070 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2008 | 38 | 0.070 |
Why?
|
| Early Diagnosis | 2 | 2019 | 187 | 0.070 |
Why?
|
| Lipid Peroxides | 1 | 2007 | 15 | 0.070 |
Why?
|
| Pyrimidines | 1 | 2011 | 407 | 0.070 |
Why?
|
| Folic Acid | 3 | 2007 | 282 | 0.070 |
Why?
|
| Heptanoic Acids | 1 | 2008 | 77 | 0.070 |
Why?
|
| Uncoupling Agents | 1 | 2007 | 5 | 0.070 |
Why?
|
| Protein Kinase C beta | 2 | 2005 | 18 | 0.070 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2007 | 33 | 0.070 |
Why?
|
| DNA | 2 | 2015 | 1421 | 0.070 |
Why?
|
| Folic Acid Deficiency | 1 | 2007 | 47 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 2 | 2019 | 234 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2008 | 186 | 0.070 |
Why?
|
| Azetidines | 1 | 2007 | 64 | 0.070 |
Why?
|
| Cardiac Output, Low | 1 | 2007 | 62 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2011 | 1868 | 0.060 |
Why?
|
| Ezetimibe | 1 | 2007 | 94 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 2234 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 2 | 2007 | 302 | 0.060 |
Why?
|
| Chemotaxis | 1 | 2006 | 59 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 429 | 0.060 |
Why?
|
| Oncogene Protein v-akt | 1 | 2006 | 33 | 0.060 |
Why?
|
| Colesevelam Hydrochloride | 1 | 2006 | 5 | 0.060 |
Why?
|
| Endotoxins | 1 | 2006 | 50 | 0.060 |
Why?
|
| Dietary Proteins | 2 | 2006 | 212 | 0.060 |
Why?
|
| RNA Stability | 2 | 2006 | 75 | 0.060 |
Why?
|
| Neutrophils | 1 | 2008 | 355 | 0.060 |
Why?
|
| beta Carotene | 1 | 2006 | 36 | 0.060 |
Why?
|
| Risk Assessment | 3 | 2021 | 3589 | 0.060 |
Why?
|
| Stereoisomerism | 2 | 2004 | 113 | 0.060 |
Why?
|
| DNA Methylation | 1 | 2013 | 1032 | 0.060 |
Why?
|
| Ethanol | 1 | 2007 | 159 | 0.060 |
Why?
|
| Genomics | 1 | 2014 | 1548 | 0.060 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2007 | 261 | 0.060 |
Why?
|
| Mitochondria | 1 | 2011 | 729 | 0.060 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2007 | 221 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2025 | 1867 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 630 | 0.060 |
Why?
|
| Cyclic AMP | 1 | 2006 | 222 | 0.060 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 216 | 0.060 |
Why?
|
| Patient Selection | 1 | 2009 | 711 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2024 | 4978 | 0.060 |
Why?
|
| Nitric Oxide Synthase | 2 | 2003 | 169 | 0.060 |
Why?
|
| Acute Coronary Syndrome | 1 | 2008 | 239 | 0.060 |
Why?
|
| Biotinylation | 1 | 2005 | 20 | 0.060 |
Why?
|
| Scrub Typhus | 1 | 2025 | 11 | 0.060 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2005 | 149 | 0.060 |
Why?
|
| Autocrine Communication | 1 | 2005 | 28 | 0.060 |
Why?
|
| Fluorescence Polarization Immunoassay | 1 | 2004 | 2 | 0.060 |
Why?
|
| Soybean Proteins | 1 | 2005 | 17 | 0.060 |
Why?
|
| DNA Damage | 1 | 2008 | 498 | 0.060 |
Why?
|
| Ferritins | 2 | 2021 | 105 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2007 | 1206 | 0.060 |
Why?
|
| Paracrine Communication | 1 | 2005 | 68 | 0.060 |
Why?
|
| Meta-Analysis as Topic | 1 | 2005 | 166 | 0.060 |
Why?
|
| Gene Expression | 1 | 2009 | 1485 | 0.060 |
Why?
|
| Endocytosis | 1 | 2005 | 120 | 0.060 |
Why?
|
| Isoflavones | 1 | 2005 | 42 | 0.060 |
Why?
|
| Genome, Viral | 1 | 2025 | 153 | 0.050 |
Why?
|
| Glutathione | 2 | 2003 | 195 | 0.050 |
Why?
|
| Administration, Intravenous | 1 | 2025 | 165 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2008 | 823 | 0.050 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2005 | 112 | 0.050 |
Why?
|
| CD36 Antigens | 1 | 2004 | 33 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2008 | 1537 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2005 | 221 | 0.050 |
Why?
|
| c-Mer Tyrosine Kinase | 1 | 2024 | 11 | 0.050 |
Why?
|
| Transglutaminases | 1 | 2024 | 27 | 0.050 |
Why?
|
| Rural Population | 2 | 2016 | 247 | 0.050 |
Why?
|
| Running | 1 | 2004 | 32 | 0.050 |
Why?
|
| Phagocytes | 1 | 2024 | 24 | 0.050 |
Why?
|
| Sesquiterpenes | 1 | 2004 | 26 | 0.050 |
Why?
|
| Terpenes | 1 | 2024 | 30 | 0.050 |
Why?
|
| Reticulocytes | 1 | 2023 | 29 | 0.050 |
Why?
|
| Models, Animal | 2 | 2020 | 452 | 0.050 |
Why?
|
| Protein Binding | 3 | 2018 | 1663 | 0.050 |
Why?
|
| Catalase | 1 | 2003 | 63 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2024 | 160 | 0.050 |
Why?
|
| Whole Genome Sequencing | 1 | 2025 | 320 | 0.050 |
Why?
|
| Beta-Globulins | 1 | 2003 | 2 | 0.050 |
Why?
|
| Paraproteins | 1 | 2003 | 3 | 0.050 |
Why?
|
| Imidazoles | 1 | 2005 | 218 | 0.050 |
Why?
|
| Homeostasis | 1 | 2007 | 690 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2003 | 184 | 0.050 |
Why?
|
| Cacao | 1 | 2002 | 8 | 0.050 |
Why?
|
| Autoimmunity | 1 | 2024 | 172 | 0.050 |
Why?
|
| Ellagic Acid | 1 | 2002 | 4 | 0.050 |
Why?
|
| Vitis | 1 | 2002 | 14 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2003 | 298 | 0.050 |
Why?
|
| Clinical Protocols | 1 | 2024 | 227 | 0.050 |
Why?
|
| Superoxide Dismutase | 1 | 2003 | 170 | 0.050 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2022 | 25 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 1598 | 0.050 |
Why?
|
| Endoglin | 1 | 2022 | 31 | 0.050 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2022 | 21 | 0.050 |
Why?
|
| Polyphenols | 1 | 2002 | 22 | 0.050 |
Why?
|
| Tertiary Care Centers | 1 | 2023 | 247 | 0.050 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2003 | 109 | 0.050 |
Why?
|
| Virulence | 1 | 2023 | 270 | 0.050 |
Why?
|
| Point-of-Care Testing | 1 | 2022 | 30 | 0.050 |
Why?
|
| Body Weight | 3 | 2017 | 971 | 0.050 |
Why?
|
| NADPH Oxidase 2 | 2 | 2013 | 38 | 0.050 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2022 | 33 | 0.050 |
Why?
|
| Interferon-gamma | 2 | 2017 | 528 | 0.050 |
Why?
|
| THP-1 Cells | 1 | 2021 | 21 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2022 | 120 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2024 | 303 | 0.040 |
Why?
|
| California | 1 | 2021 | 124 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2003 | 450 | 0.040 |
Why?
|
| Comorbidity | 2 | 2019 | 1562 | 0.040 |
Why?
|
| Pre-Eclampsia | 1 | 2003 | 220 | 0.040 |
Why?
|
| Cross-Over Studies | 2 | 2014 | 326 | 0.040 |
Why?
|
| Isoleucine | 1 | 2020 | 25 | 0.040 |
Why?
|
| Kynurenine | 1 | 2021 | 26 | 0.040 |
Why?
|
| Area Under Curve | 3 | 2010 | 302 | 0.040 |
Why?
|
| Caspase 1 | 1 | 2020 | 45 | 0.040 |
Why?
|
| Diabetes Complications | 1 | 2002 | 194 | 0.040 |
Why?
|
| Logistic Models | 2 | 2018 | 1789 | 0.040 |
Why?
|
| Tryptophan | 1 | 2021 | 94 | 0.040 |
Why?
|
| Enterochromaffin Cells | 1 | 2020 | 11 | 0.040 |
Why?
|
| Receptors, Serotonin | 1 | 2020 | 36 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2025 | 937 | 0.040 |
Why?
|
| Carnitine | 1 | 2020 | 68 | 0.040 |
Why?
|
| Germ-Free Life | 1 | 2020 | 61 | 0.040 |
Why?
|
| Partial Thromboplastin Time | 1 | 2020 | 44 | 0.040 |
Why?
|
| Phosphoproteins | 2 | 2018 | 420 | 0.040 |
Why?
|
| Acylation | 1 | 2020 | 16 | 0.040 |
Why?
|
| Peptides | 1 | 2004 | 830 | 0.040 |
Why?
|
| Heme Oxygenase-1 | 2 | 2013 | 30 | 0.040 |
Why?
|
| Acetates | 1 | 2020 | 81 | 0.040 |
Why?
|
| Mitochondria, Muscle | 1 | 2020 | 36 | 0.040 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2020 | 164 | 0.040 |
Why?
|
| Apoptosis | 3 | 2012 | 1824 | 0.040 |
Why?
|
| Indoles | 1 | 2021 | 199 | 0.040 |
Why?
|
| Hypertension, Pulmonary | 1 | 2024 | 453 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2002 | 275 | 0.040 |
Why?
|
| Stroke | 1 | 2007 | 1028 | 0.040 |
Why?
|
| Sarcopenia | 1 | 2020 | 55 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 2022 | 489 | 0.040 |
Why?
|
| Body Composition | 2 | 2017 | 538 | 0.040 |
Why?
|
| Hemoglobin A | 1 | 2019 | 22 | 0.040 |
Why?
|
| Blood Platelets | 1 | 2002 | 312 | 0.040 |
Why?
|
| Acrolein | 1 | 1999 | 11 | 0.040 |
Why?
|
| Respiratory Sinus Arrhythmia | 1 | 2018 | 10 | 0.040 |
Why?
|
| Acid-Base Imbalance | 1 | 2019 | 24 | 0.040 |
Why?
|
| Heart | 1 | 2003 | 650 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 2020 | 167 | 0.040 |
Why?
|
| Immunoprecipitation | 2 | 2010 | 187 | 0.040 |
Why?
|
| Mice, Knockout, ApoE | 1 | 2018 | 3 | 0.040 |
Why?
|
| Acid-Base Equilibrium | 1 | 2019 | 60 | 0.040 |
Why?
|
| Echocardiography | 1 | 2024 | 1115 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2018 | 47 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2013 | 1127 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2002 | 1433 | 0.040 |
Why?
|
| Waist-Height Ratio | 1 | 2018 | 4 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2019 | 425 | 0.030 |
Why?
|
| Exercise | 1 | 2004 | 845 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2025 | 1728 | 0.030 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 297 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2004 | 6695 | 0.030 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2022 | 320 | 0.030 |
Why?
|
| Food | 1 | 2018 | 120 | 0.030 |
Why?
|
| Organoids | 1 | 2020 | 282 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2020 | 494 | 0.030 |
Why?
|
| Gene-Environment Interaction | 1 | 2018 | 126 | 0.030 |
Why?
|
| Interleukin-5 | 1 | 2017 | 49 | 0.030 |
Why?
|
| Urea Cycle Disorders, Inborn | 1 | 2018 | 84 | 0.030 |
Why?
|
| Glucosyltransferases | 1 | 2017 | 39 | 0.030 |
Why?
|
| Sweetening Agents | 1 | 2017 | 36 | 0.030 |
Why?
|
| Rabbits | 2 | 2010 | 626 | 0.030 |
Why?
|
| Siblings | 1 | 2018 | 202 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2021 | 552 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2018 | 220 | 0.030 |
Why?
|
| Critical Illness | 1 | 2021 | 604 | 0.030 |
Why?
|
| Motor Activity | 1 | 2020 | 504 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2018 | 560 | 0.030 |
Why?
|
| Veterans | 2 | 2021 | 1742 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2017 | 124 | 0.030 |
Why?
|
| Minerals | 1 | 2016 | 58 | 0.030 |
Why?
|
| Saponins | 1 | 1996 | 21 | 0.030 |
Why?
|
| DNA Repair | 1 | 2020 | 549 | 0.030 |
Why?
|
| Biogenic Amines | 1 | 1996 | 17 | 0.030 |
Why?
|
| Africa | 1 | 2016 | 135 | 0.030 |
Why?
|
| Anthelmintics | 1 | 2016 | 55 | 0.030 |
Why?
|
| Health Personnel | 1 | 2021 | 535 | 0.030 |
Why?
|
| Gastrointestinal Diseases | 1 | 2019 | 337 | 0.030 |
Why?
|
| Community-Acquired Infections | 1 | 2018 | 249 | 0.030 |
Why?
|
| Environment | 1 | 2016 | 150 | 0.030 |
Why?
|
| Proteomics | 1 | 2020 | 563 | 0.030 |
Why?
|
| Breath Tests | 1 | 2016 | 182 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 1314 | 0.030 |
Why?
|
| Malawi | 1 | 2016 | 312 | 0.030 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2015 | 16 | 0.030 |
Why?
|
| Acetylation | 1 | 2015 | 181 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2018 | 467 | 0.030 |
Why?
|
| 3T3-L1 Cells | 1 | 2015 | 52 | 0.030 |
Why?
|
| Antibodies, Antinuclear | 1 | 2015 | 31 | 0.030 |
Why?
|
| Acute-Phase Proteins | 1 | 2015 | 42 | 0.030 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2015 | 42 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2015 | 73 | 0.030 |
Why?
|
| Anxiety | 1 | 2022 | 964 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 2 | 2011 | 80 | 0.030 |
Why?
|
| Lung Diseases | 1 | 1999 | 396 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2018 | 1216 | 0.030 |
Why?
|
| Gulf War | 1 | 2014 | 10 | 0.030 |
Why?
|
| Alanine Transaminase | 2 | 2011 | 154 | 0.030 |
Why?
|
| Cognition | 1 | 2020 | 785 | 0.030 |
Why?
|
| Adipogenesis | 1 | 2015 | 80 | 0.030 |
Why?
|
| Biological Transport, Active | 1 | 2014 | 73 | 0.030 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2014 | 44 | 0.030 |
Why?
|
| Bile Acids and Salts | 1 | 1996 | 243 | 0.030 |
Why?
|
| Chorioamnionitis | 1 | 2014 | 44 | 0.030 |
Why?
|
| Adipocytes | 1 | 2015 | 168 | 0.030 |
Why?
|
| Heart Failure | 1 | 2007 | 2288 | 0.030 |
Why?
|
| Ribotyping | 1 | 2014 | 49 | 0.030 |
Why?
|
| Child Development | 1 | 2016 | 266 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2020 | 973 | 0.030 |
Why?
|
| ADAM17 Protein | 1 | 2013 | 4 | 0.030 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2013 | 4 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2014 | 225 | 0.030 |
Why?
|
| Weight Gain | 1 | 1996 | 377 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2025 | 3715 | 0.030 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2020 | 669 | 0.030 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2013 | 15 | 0.020 |
Why?
|
| Uric Acid | 2 | 2004 | 109 | 0.020 |
Why?
|
| Adenosylhomocysteinase | 1 | 2013 | 3 | 0.020 |
Why?
|
| Penicillamine | 1 | 2013 | 5 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2018 | 1047 | 0.020 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2013 | 16 | 0.020 |
Why?
|
| Free Radical Scavengers | 2 | 2003 | 53 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2013 | 226 | 0.020 |
Why?
|
| Betaine | 1 | 2013 | 19 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 2311 | 0.020 |
Why?
|
| Imidoesters | 1 | 2012 | 2 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2013 | 109 | 0.020 |
Why?
|
| Glucosinolates | 1 | 2012 | 2 | 0.020 |
Why?
|
| Sulfoxides | 1 | 2012 | 11 | 0.020 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2013 | 19 | 0.020 |
Why?
|
| Peptide Library | 1 | 2013 | 57 | 0.020 |
Why?
|
| NF-E2 Transcription Factor | 1 | 2012 | 1 | 0.020 |
Why?
|
| Isothiocyanates | 1 | 2012 | 12 | 0.020 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2013 | 33 | 0.020 |
Why?
|
| India | 2 | 2003 | 228 | 0.020 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2012 | 26 | 0.020 |
Why?
|
| Amiodarone | 1 | 1992 | 47 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2014 | 482 | 0.020 |
Why?
|
| Pyrazolones | 1 | 2012 | 2 | 0.020 |
Why?
|
| Copper | 1 | 2013 | 72 | 0.020 |
Why?
|
| NADPH Oxidase 1 | 1 | 2012 | 2 | 0.020 |
Why?
|
| Oximes | 1 | 2012 | 53 | 0.020 |
Why?
|
| NADPH Oxidase 4 | 1 | 2012 | 13 | 0.020 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2012 | 50 | 0.020 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 2012 | 9 | 0.020 |
Why?
|
| Anticarcinogenic Agents | 1 | 2012 | 46 | 0.020 |
Why?
|
| Dactinomycin | 1 | 2012 | 48 | 0.020 |
Why?
|
| Molecular Docking Simulation | 1 | 2013 | 133 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2013 | 104 | 0.020 |
Why?
|
| Fas Ligand Protein | 1 | 2012 | 35 | 0.020 |
Why?
|
| Cattle | 1 | 2013 | 539 | 0.020 |
Why?
|
| Length of Stay | 1 | 2018 | 1378 | 0.020 |
Why?
|
| Histones | 1 | 2015 | 503 | 0.020 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2013 | 122 | 0.020 |
Why?
|
| Ligation | 1 | 2012 | 136 | 0.020 |
Why?
|
| Smad3 Protein | 1 | 2012 | 52 | 0.020 |
Why?
|
| Bile Ducts | 1 | 2012 | 52 | 0.020 |
Why?
|
| Phylogeny | 1 | 2014 | 687 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 733 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2020 | 1162 | 0.020 |
Why?
|
| Obstetrics | 1 | 2014 | 245 | 0.020 |
Why?
|
| Actins | 1 | 2013 | 311 | 0.020 |
Why?
|
| Rosuvastatin Calcium | 1 | 2011 | 42 | 0.020 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2013 | 148 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2015 | 763 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 286 | 0.020 |
Why?
|
| Pyridones | 1 | 2012 | 137 | 0.020 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2010 | 14 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2013 | 371 | 0.020 |
Why?
|
| Sulfur | 1 | 2010 | 11 | 0.020 |
Why?
|
| Cystathionine | 1 | 2010 | 5 | 0.020 |
Why?
|
| Aminobutyrates | 1 | 2010 | 9 | 0.020 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 2010 | 32 | 0.020 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2010 | 24 | 0.020 |
Why?
|
| Trichothecenes | 1 | 2010 | 3 | 0.020 |
Why?
|
| HT29 Cells | 1 | 2010 | 42 | 0.020 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2010 | 39 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2010 | 37 | 0.020 |
Why?
|
| Porins | 1 | 2010 | 38 | 0.020 |
Why?
|
| Coronary Vessels | 2 | 2005 | 524 | 0.020 |
Why?
|
| HSP72 Heat-Shock Proteins | 1 | 2010 | 2 | 0.020 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2010 | 39 | 0.020 |
Why?
|
| Biological Transport | 1 | 2010 | 326 | 0.020 |
Why?
|
| Chaperonin 60 | 1 | 2010 | 31 | 0.020 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2010 | 62 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2010 | 126 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2010 | 112 | 0.020 |
Why?
|
| Neuropeptides | 1 | 2010 | 113 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 445 | 0.020 |
Why?
|
| Cell Separation | 1 | 2010 | 219 | 0.020 |
Why?
|
| Lipopeptides | 1 | 2009 | 33 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2012 | 768 | 0.020 |
Why?
|
| Arterioles | 1 | 2009 | 36 | 0.020 |
Why?
|
| Nitroprusside | 1 | 2009 | 36 | 0.020 |
Why?
|
| Acetylcholine | 1 | 2009 | 82 | 0.020 |
Why?
|
| Collagen | 1 | 2010 | 292 | 0.020 |
Why?
|
| Polyethylene | 1 | 2008 | 15 | 0.020 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2013 | 393 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2010 | 299 | 0.020 |
Why?
|
| GTP Cyclohydrolase | 1 | 2007 | 7 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2008 | 127 | 0.020 |
Why?
|
| Alcoholism | 1 | 2010 | 242 | 0.020 |
Why?
|
| Swine, Miniature | 1 | 2007 | 53 | 0.020 |
Why?
|
| Electron Transport | 1 | 2007 | 60 | 0.020 |
Why?
|
| Coenzymes | 1 | 2007 | 11 | 0.020 |
Why?
|
| Dimerization | 1 | 2007 | 135 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 2007 | 92 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 2007 | 90 | 0.020 |
Why?
|
| Neutralization Tests | 1 | 2007 | 225 | 0.020 |
Why?
|
| Necrosis | 1 | 2007 | 192 | 0.020 |
Why?
|
| Apolipoprotein A-I | 1 | 2007 | 78 | 0.020 |
Why?
|
| Ligands | 1 | 2008 | 477 | 0.020 |
Why?
|
| Adenylyl Cyclase Inhibitors | 1 | 2006 | 5 | 0.020 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2007 | 53 | 0.020 |
Why?
|
| Life Style | 1 | 2010 | 434 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 1206 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 2006 | 55 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 236 | 0.020 |
Why?
|
| CREB-Binding Protein | 1 | 2006 | 55 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2007 | 240 | 0.020 |
Why?
|
| Azides | 1 | 2006 | 11 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2006 | 95 | 0.020 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2006 | 28 | 0.020 |
Why?
|
| Tunica Intima | 1 | 2006 | 57 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2006 | 60 | 0.020 |
Why?
|
| Linear Models | 1 | 2007 | 687 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 2006 | 118 | 0.010 |
Why?
|
| Prevalence | 1 | 2012 | 2614 | 0.010 |
Why?
|
| Dietary Carbohydrates | 1 | 2006 | 107 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 2005 | 64 | 0.010 |
Why?
|
| Homocystine | 1 | 2004 | 3 | 0.010 |
Why?
|
| Genistein | 1 | 2005 | 39 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 2005 | 122 | 0.010 |
Why?
|
| TYK2 Kinase | 1 | 2004 | 4 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2006 | 226 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 449 | 0.010 |
Why?
|
| Swine | 1 | 2007 | 1173 | 0.010 |
Why?
|
| Galactans | 1 | 2003 | 2 | 0.010 |
Why?
|
| Plant Gums | 1 | 2003 | 2 | 0.010 |
Why?
|
| Trigonella | 1 | 2003 | 2 | 0.010 |
Why?
|
| Receptors, Lipoprotein | 1 | 2003 | 10 | 0.010 |
Why?
|
| Coronary Stenosis | 1 | 2004 | 78 | 0.010 |
Why?
|
| Peroxynitrous Acid | 1 | 2003 | 8 | 0.010 |
Why?
|
| Mannans | 1 | 2003 | 14 | 0.010 |
Why?
|
| Islam | 1 | 2003 | 11 | 0.010 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2003 | 45 | 0.010 |
Why?
|
| Blood Protein Electrophoresis | 1 | 2003 | 5 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 2003 | 147 | 0.010 |
Why?
|
| Solubility | 1 | 2003 | 123 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2003 | 40 | 0.010 |
Why?
|
| Lipase | 1 | 2003 | 86 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2003 | 90 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2004 | 220 | 0.010 |
Why?
|
| Paraproteinemias | 1 | 2003 | 21 | 0.010 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2003 | 163 | 0.010 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2003 | 111 | 0.010 |
Why?
|
| Onium Compounds | 1 | 2002 | 4 | 0.010 |
Why?
|
| Mesylates | 1 | 2002 | 3 | 0.010 |
Why?
|
| Acetophenones | 1 | 2002 | 11 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2002 | 7 | 0.010 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2004 | 177 | 0.010 |
Why?
|
| Anthropometry | 1 | 2003 | 190 | 0.010 |
Why?
|
| Erythropoietin | 1 | 2003 | 104 | 0.010 |
Why?
|
| Erythrocyte Indices | 1 | 2002 | 12 | 0.010 |
Why?
|
| Biphenyl Compounds | 1 | 2002 | 64 | 0.010 |
Why?
|
| Blood Proteins | 1 | 2002 | 130 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2004 | 452 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2003 | 951 | 0.010 |
Why?
|
| Sulfhydryl Compounds | 1 | 1999 | 55 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2003 | 1199 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2006 | 979 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 3502 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2002 | 1380 | 0.010 |
Why?
|
| Survival Rate | 1 | 2002 | 2111 | 0.010 |
Why?
|
| Acute Disease | 1 | 1999 | 1142 | 0.010 |
Why?
|
| Mutation | 1 | 2006 | 5947 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 1992 | 92 | 0.010 |
Why?
|
| Lung | 1 | 1999 | 1522 | 0.010 |
Why?
|